SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001821392-20-000001
Filing Date
2020-08-24
Accepted
2020-08-24 14:07:01
Documents
1
Effectiveness Date
2020-08-24
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 5481
  Complete submission text file 0001821392-20-000001.txt   6512
Mailing Address 5777 CROWNTREE LANE APT 202 ORLANDO FL 32829
Business Address 5777 CROWNTREE LANE APT 202 ORLANDO FL 32829 415-323-5252
Enveda Therapeutics, Inc. (Filer) CIK: 0001821392 (see all company filings)

IRS No.: 834701687 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-373933 | Film No.: 201126619